Operating Expenses

R&D

DuPont de Nemours, Inc. R&D decreased by 66.4% to $47.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.0%, from $50.00M to $47.00M.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$133.00M$137.00M$148.00M$143.00M$141.00M$129.00M$123.00M$127.00M$125.00M$128.00M$125.00M$134.00M$127.00M$50.00M$142.00M$140.00M$47.00M
QoQ Change+3.0%+8.0%-3.4%-1.4%-8.5%-4.7%+3.3%-1.6%+2.4%-2.3%+7.2%-5.2%-60.6%+184.0%-1.4%-66.4%
YoY Change+6.0%-5.8%-16.9%-11.2%-11.3%-0.8%-1.6%+7.2%-0.8%-60.0%+6.0%+10.2%-6.0%
Range$47.00M$148.00M
CAGR-22.9%
Avg YoY Growth-6.5%
Median YoY Growth-1.6%
Current Streak2 quarters decline

Frequently Asked Questions

What is DuPont de Nemours, Inc.'s r&d?
DuPont de Nemours, Inc. (DD) reported r&d of $47.00M in Q1 2026.
How has DuPont de Nemours, Inc.'s r&d changed year-over-year?
DuPont de Nemours, Inc.'s r&d decreased by 6.0% year-over-year, from $50.00M to $47.00M.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.